BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25765855)

  • 1. TP53 Y220C Is a Hotspot Mutation in Oropharyngeal Squamous Cell Carcinoma.
    van Kempen PM; Verdam FJ; de Poel E; Braunius WW; de Weger RA; van Es RJ; Grolman W; Willems SM
    Pathobiology; 2015; 82(1):21-27. PubMed ID: 25765855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting therapeutic responses in head and neck squamous cell carcinoma from
    Wei M; Zhi J; Li L; Wang W
    Transl Cancer Res; 2023 Dec; 12(12):3604-3617. PubMed ID: 38197078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The
    Moe SE; Erland FA; Fromreide S; Lybak S; Brydoy M; Dongre HN; Dhayalan SM; Costea DE; Vintermyr OK; Aarstad HJ
    Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times.
    Eriksen JG; Alsner J; Steiniche T; Overgaard J
    Radiother Oncol; 2005 Aug; 76(2):135-42. PubMed ID: 16024113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck.
    Ito D; Visus C; Hoffmann TK; Balz V; Bier H; Appella E; Whiteside TL; Ferris RL; DeLeo AB
    Int J Cancer; 2007 Jun; 120(12):2618-24. PubMed ID: 17294448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.
    Lindenbergh-van der Plas M; Brakenhoff RH; Kuik DJ; Buijze M; Bloemena E; Snijders PJ; Leemans CR; Braakhuis BJ
    Clin Cancer Res; 2011 Jun; 17(11):3733-41. PubMed ID: 21467160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
    van Monsjou HS; Schaapveld M; van den Brekel MW; Balm AJ
    Oral Oncol; 2015 Oct; 51(10):901-7. PubMed ID: 26216340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand.
    Dechaphunkul A; Thongwatchara P; Thongsuksai P; Dechaphunkul T; Geater SL
    J Pathol Transl Med; 2022 May; 56(3):126-133. PubMed ID: 35209701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic expression imbalance of TP53 mutated and polymorphic alleles in head and neck tumors.
    Ganci F; Conti S; Fontemaggi G; Manciocco V; Donzelli S; Covello R; Muti P; Strano S; Blandino G; Spriano G
    OMICS; 2011 Jun; 15(6):375-81. PubMed ID: 21348641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck].
    Golusinski P; Lamperska K; Pazdrowski J; Golusinski W
    Otolaryngol Pol; 2011; 65(2):114-21. PubMed ID: 21735667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA mutations in head and neck squamous cell carcinoma.
    Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
    Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.
    Wichmann G; Rosolowski M; Krohn K; Kreuz M; Boehm A; Reiche A; Scharrer U; Halama D; Bertolini J; Bauer U; Holzinger D; Pawlita M; Hess J; Engel C; Hasenclever D; Scholz M; Ahnert P; Kirsten H; Hemprich A; Wittekind C; Herbarth O; Horn F; Dietz A; Loeffler M;
    Int J Cancer; 2015 Dec; 137(12):2846-57. PubMed ID: 26095926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma.
    Omura G; Ando M; Ebihara Y; Saito Y; Kobayashi K; Fukuoka O; Akashi K; Yoshida M; Asakage T; Yamasoba T
    BMC Cancer; 2017 Dec; 17(1):898. PubMed ID: 29282038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
    Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
    Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ
    Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
    Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
    Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas.
    Ibrahim SO; Lillehaug JR; Vasstrand EN
    Anticancer Res; 2003; 23(6C):4593-600. PubMed ID: 14981901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review.
    Tornesello ML; Buonaguro L; Buonaguro FM
    Gynecol Oncol; 2013 Mar; 128(3):442-8. PubMed ID: 23168175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection.
    Eicheler W; Zips D; Dörfler A; Grénman R; Baumann M
    J Histochem Cytochem; 2002 Feb; 50(2):197-204. PubMed ID: 11799138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.